Radheshyam Naik

Excellent CBR and prolonged PFS in non-squamous NSCLC with oral CA-170, an inhibitor of VISTA and PD-L1

Venkatraman Radhakrishnan, Shripad Banavali, Sudeep Gupta et al. · Annals of Oncology · 2019 · 42 citations · Full text

Oncology, Novel Therapy, Clinical Therapeutic +8

Epidermal growth factor receptor mutation in non-small-cell lung carcinomas: A retrospective analysis of 1036 lung cancer specimens from a network of tertiary cancer care centers in India

VH Veldore, R. M. Rao, S Kakara et al. · Indian Journal of Cancer · 2013 · 30 citations

Doceaqualip in a patient with prostate cancer who had an allergic reaction to conventional docetaxel: A case report

Radheshyam Naik, Mujtaba Khan · Molecular and Clinical Oncology · 2017 · 22 citations · Full text

Urology, Oncology, Conventional Docetaxel +13

The role of p53 and ki67 in predicting clinical outcome in breast cancer patients

BhanuPrakash Lalkota, B. Srinivasa, M. Shiv Shankara Swamy et al. · Journal of Cancer Research and Therapeutics · 2023 · 15 citations · Full text

Genomic profiling in a homogeneous molecular subtype of non-small cell lung cancer: An effort to explore new drug targets

VidyaH Veldore, S. Patil, CT Satheesh et al. · Indian Journal of Cancer · 2015 · 14 citations